Publication | Open Access

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

Doxorubicin Versus DoxorubicinMedicineGynecologyDefinitive ResultsCancer TreatmentEndometrial CarcinomaOncologyRadiation OncologyCancer ResearchGynecology OncologyMolecular OncologyEndocrine-related Cancer